Ferrlecit Solution For Injection 12.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Ferrlecit: Solution for injection (12.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

SODIUM FERRIC GLUCONATE COMPLEX (SOE dee um FER ik GLOO koe nate KOM pleks) is an iron replacement. It is used with epoetin therapy to treat low iron levels in patients who are receiving hemodialysis.

In-Depth Information
Select a Medication

Ferrlecit 62.5mg/5ml Solution for Injection

NDC: 000242792
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Iron-deficiency Anemia

Storage Information
Do not freeze
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Ferrlecit 62.5mg/5ml Solution for Injection

Reported Side Effects for Ferrlecit 62.5mg/5ml Solution for Injection

Rhinitis Incidence:
3.0-9.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
3.0-15.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
3.0-15.0%*
Severity: MILD
Onset: EARLY
Blood Clot Incidence:
3.4-6.0%*
Severity: SEVERE
Onset: DELAYED
Tired Incidence:
3.8-6.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
4.1-7.0%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
4.5-8.0%*
Severity: MILD
Onset: DELAYED
Back Pain Incidence:
4.5%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
5.0-21.0%*
Severity: MODERATE
Onset: RAPID
Shortness Of Breath Incidence:
5.8-11.0%*
Severity: MODERATE
Onset: EARLY
Upset Stomach Incidence:
6.0-35.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
6.0%*
Severity: MILD
Onset: RAPID
Sore Throat Incidence:
6.0-12.0%*
Severity: MILD
Onset: DELAYED
Fainting Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Cough Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
High Potassium Level Incidence:
6.0%*
Severity: SEVERE
Onset: DELAYED
Fluid Retention Incidence:
6.8%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
7.0-29.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
8.0-35.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
9.0-35.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
10.0%*
Severity: MODERATE
Onset: EARLY
High Blood Pressure Incidence:
13.0-23.0%*
Severity: MODERATE
Onset: EARLY
Lightheadedness Incidence:
13.0%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
21.6-41.0%*
Severity: MODERATE
Onset: RAPID
Injection Site Reaction Incidence:
33.0%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ferrlecit

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5